Pushing Boundaries, Advancing Science
Video
Collaborative Research Training
Discover the UF Pharmaceutical Sciences graduate program and learn about our comprehensive and collaborative research training across the five concentrations.
Play Video
Research Across the Drug Life Cycle
News
Competition and collaboration highlight the UF College of Pharmacy’s 37th Annual Research Showcase
This year’s event featured more than 110 posters, 12 oral presentations and a keynote address from Angela Kashuba, B.Sc.Phm., Pharm.D., DABCP, FCP, the John A. and Margaret P. McNeill, Sr. Distinguished Professor and the dean of the University of North Carolina Eshelman School of Pharmacy.
Select Your Research Path
Five Research Concentrations
Pursue your Ph.D. in one of our five concentrations, spanning the breadth of pharmaceutical sciences research.
Medicinal Chemistry
Drug discovery and development with focuses on biochemistry, natural products and AI-driven therapies.
Pharmacodynamics
Understand mechanisms of disease and develop new therapeutic solutions through cellular physiology, systems physiology and pharmacology.
Pharmaceutics
Improve drug therapies using pharmacokinetics, pharmacometrics and biotechnology.
Clinical Pharmaceutical Sciences
Discover genetic and nongenetic factors that contribute to variability in drug response.
Pharmaceutical Outcomes and Policy
Understand medication use in large populations, using big data and advanced methods in study design, measurement and analysis.
College Research NEWS
Genetics may predict benefits of kava in reducing lung cancer risk
Researchers bolstered their findings that kava may reduce lung cancer risk caused by tobacco smoke.
Field of nanomedicine takes center stage as UF hosts nanoDDS symposium
The 22nd International Nanomedicine and Drug Delivery Symposium was held in Florida for the first time.
Strengthening Muscle Research
The UF Office of Research featured Dr. Siobhan Malany’s muscle research in space in the fall edition of Explore Magazine.
Dr. Fan Zhang receives NIH grant to study interactions of myeloid cells with nanotherapeutics
The $1.9 million grant from the National Institute of General Medical Sciences focuses on nanotherapeutic treatments for diseases like cancer, sepsis, and autoimmune disorders.
